Eagle Pharmaceuticals Inc (EGRX)

followers · Follow

Sector:	HEALTH CARE
Industry:	PHARMACEUTICALS
SIC:	PHARMACEUTICAL PREPARATIONS
CEO:	Scott L. Tarriff
Employees:	100
Web site:	eagleus.com
50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ, 07677 201-326-5300

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Eagle Pharmaceuticals, Inc. focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology. The company offers Ryanodex for malignant hyperthermia; Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure.

Please log in first to see chart

Eagle Pharmaceuticals Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available